Transient Neurologic Symptoms following spinal Lignocaine and Bupivacaine for caesarean delivery at Mulago Hospital, a randomised trial.

Not Applicable

• Conditions: Nervous System Diseases; its comparing safety profile for the different drugs in the randomised trial.

• Registration Number: PACTR201306000510382
• Lead Sponsor: Dr Aggrey Lubikire(self)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-02-26
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 180

Inclusion Criteria

only ASA 1 and 2 and E , patients above 18 and provide informed consent to participate in the study will be enrolled.

Exclusion Criteria

Patients with previous neurologic deficits, periperal neuropathy like diabetes, previous back injuries.
Failed spinal :patients who receive spinal blockade with either Lignocaine or Bupivacaine, and the drug fails to take, then get general anaesthesia will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified